Geode Capital Management LLC Grows Stake in Kewaunee Scientific Co. (NASDAQ:KEQU)

Geode Capital Management LLC grew its holdings in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) by 8.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,784 shares of the technology company’s stock after buying an additional 1,941 shares during the period. Geode Capital Management LLC owned 0.83% of Kewaunee Scientific worth $792,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Barclays PLC purchased a new position in Kewaunee Scientific during the 3rd quarter valued at $121,000. State Street Corp bought a new stake in shares of Kewaunee Scientific during the 3rd quarter valued at about $266,000. De Lisle Partners LLP increased its position in shares of Kewaunee Scientific by 36.6% during the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares during the period. Ritholtz Wealth Management raised its stake in Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after buying an additional 2,156 shares in the last quarter. Finally, Heron Bay Capital Management purchased a new stake in Kewaunee Scientific in the second quarter worth about $252,000. Institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Price Performance

KEQU opened at $57.73 on Friday. Kewaunee Scientific Co. has a 12-month low of $27.00 and a 12-month high of $67.20. The company has a market cap of $165.80 million, a price-to-earnings ratio of 9.15 and a beta of 0.72. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. The stock has a fifty day simple moving average of $48.37 and a two-hundred day simple moving average of $44.91.

Analyst Ratings Changes

Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.

Insider Buying and Selling

In other Kewaunee Scientific news, VP Elizabeth D. Phillips sold 1,850 shares of Kewaunee Scientific stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the transaction, the vice president now owns 13,591 shares in the company, valued at approximately $736,224.47. The trade was a 11.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Donald T. Gardner III sold 2,049 shares of the stock in a transaction on Tuesday, December 24th. The stock was sold at an average price of $58.19, for a total value of $119,231.31. Following the completion of the sale, the chief financial officer now directly owns 22,615 shares in the company, valued at approximately $1,315,966.85. This represents a 8.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 9,369 shares of company stock worth $572,751 in the last three months. 14.20% of the stock is owned by corporate insiders.

Kewaunee Scientific Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.